PharmiWeb

Avenacy to Attend 2026 DCAT Week

Avenacy, a specialty pharmaceutical company focused on supplying critical injectable medications, today announced that it ...
PharmiWeb

NeoGenomics’ PanTracer LBx Receives Medicare Coverage, Expanding Access to Comprehensive Liquid Biopsy Profiling

NeoGenomics, Inc. (NASDAQ: NEO), a leading provider of oncology diagnostic solutions that enable precision medicine, today ...
PharmiWeb

RevnaBio Secures Triple International Laboratory Accreditation to Expand Precision Medicine and Clinical Research Infrastructure in Africa

A2LA accreditation across ISO 15189, ISO 20387, and ISO/IEC 17043 strengthens diagnostic quality for patients while enabling ...
PharmiWeb

GCE® Launches Gascontrol.com Website Showcasing Its Complete Gas Control Portfolio for Speciality, Medical, and Industrial Applications

ZUG, Switzerland--(BUSINESS WIRE)--$esab #ESAB--GCE®, a global market leader for gas control equipment, has launched ...
PharmiWeb

Coya Therapeutics Provides a Corporate Update and Reports Fiscal 2025 Financial Results

Coya Therapeutics, Inc. (NASDAQ: COYA) (“Coya” or the “Company”), a clinical-stage biotechnology company developing biologics intended to enhance T-cell (Treg) function in patients with ...
PharmiWeb

Magdalena Biosciences, a Joint Venture Between Jaguar Health and Filament Health, Initiates Preclinical Study of Coca for Appetite Suppression

Whole leaf coca extract under evaluation is Magdalena's drug candidate for post-GLP-1 weight loss management SAN FRANCISCO, CA / ACCESS Newswire / March 16, 2026 / Jaguar Health, Inc. (NASDAQ:JAGX) ...
PharmiWeb

Patient Safety Movement Foundation Honors Global Leaders Advancing Patient Safety at the 2025 World Patient Safety, Science & Technology Summit

Humanitarian Awards recognize Dr. Jill Biden, Dr. Najm Meshkati and Dr. Michelle Schreiber; Patient Safety Fellowship Valedictorians honored for advancing safer care worldwide IRVINE, CA / ACCESS ...
PharmiWeb

Merck Highlights New Data from Cardio-Pulmonary Pipeline at ACC.26 Showcasing Commitment to Advance Innovative Research

Late-breaking presentation of results from the Phase 3 CORALreef AddOn trial evaluating enlicitide decanoate, Merck’s investigational oral PCSK9 inhibitor, which may help address the cardiovascular ...
PharmiWeb

uBriGene Congratulates Strategic Partner Grit Biotechnologies on FDA IND Clearance for Its Next-Generation GT307 TIL Therapy

GERMANTOWN, MD / ACCESS Newswire / March 16, 2026 / uBriGene Biosciences (uBriGene), a global CDMO leader, is excited to announce that its strategic partner, Grit Biotechnologies, has received FDA ...
PharmiWeb

Black Book Research Releases United Kingdom State of Acute Care EHR and Digital Healthcare 2026 Market Report

New 50-page market briefing finds the UK acute care IT market is being reshaped by four distinct NHS buying environments, near-universal EPR adoption pressure, NHS App scale, interoperability demands, ...
PharmiWeb

INVESTOR NOTICE: Boston Scientific Corporation Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit, Robbins Geller Rudman & Dowd LLP Announces

Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Boston Scientific Corporation (NYSE: BSX) common stock between July 23, 2025 and February 3, 2026, both dates inclusive (the ...
PharmiWeb

GEN Receives Ethical Approval to Launch Phase II Clinical Trial for SUL-238 Targeting Mitochondrial Dysfunction in Patients with Parkinson’s Disease

GEN announces approval in the Netherlands to initiate patient enrollment in April 2026 for the Phase II Proof of Concept trial of its novel drug candidate SUL-238, Targeting Mitochondrial Dysfunction ...